Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania
Abstract
:1. Introduction
2. Materials and Methods
2.1. Ethical Approval
2.2. Study Design
2.3. Study Sampling and Recruitment
2.4. Data Collection
2.5. Data Analysis
3. Results
3.1. Demographic Characteristics of Participants
3.2. Thematic Analysis of Content
3.2.1. Theme 1: Knowledge about Medication Safety, ADRs, and Pharmacovigilance
Subtheme 1: Knowledge about Definitions
Subtheme 2: Memories about ADRs
Subtheme 3: Self-Medication Practices
Subtheme 4: Causes of ADRs
3.2.2. Theme 2: Information Sources about Medicines and ADRs
Subtheme 1: Pharmacists and Physicians as Information Sources
Subtheme 2: Leaflets as an Information Source
3.2.3. Theme 3: Knowledge about ADR Reporting
3.2.4. Theme 4: Attitudes towards ADR Reporting
3.2.5. Theme 5: Benefits of ADR Reporting
3.2.6. Theme 6: Barriers to ADR Reporting
Subtheme 1: Lack of Time to Report ADRs
Subtheme 2: Lack of Interest from Physicians and Pharmacists
Subtheme 3: Low Physician and Pharmacist Motivation
Subtheme 4: Lack of Education
Subtheme 5: Physicians’ Attitudes
Subtheme 6: Nocebo Effect
Subtheme 7: Lack of a Proper Reporting System
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Inch, J.; Watson, M.C.; Anakwe-Umeh, S. Patient versus healthcare professional spontaneous adverse drug reaction reporting: A systematic review. Drug Saf. 2012, 35, 807–818. [Google Scholar] [CrossRef]
- European Parliament. Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 Amending, as Regards Pharmacovigilance, Directive 2001/83/EC on the Community Code Relating to Medicinal Products for Human Use Text with EEA Relevance; OJ L 348, 31.12. 2010; European Parliament: Brussels, Belgium, 2010; pp. 74–99. [Google Scholar]
- Blenkinsopp, A.; Wilkie, P.; Wang, M.; Routledge, P.A. Patient reporting of suspected adverse drug reactions: A review of published literature and international experience. Br. J. Clin. Pharmacol. 2007, 63, 148–156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Hunsel, F.; Härmark, L.; Pal, S.; Olsson, S.; van Grootheest, K. Experiences with adverse drug reaction reporting by patients: An 11-country survey. Drug Saf. 2012, 35, 45–60. [Google Scholar] [CrossRef] [PubMed]
- Anderson, C.; Krska, J.; Murphy, E.; Avery, A.; Yellow Card Study, C. The importance of direct patient reporting of suspected adverse drug reactions: A patient perspective. Br. J. Clin. Pharmacol. 2011, 72, 806–822. [Google Scholar] [CrossRef] [Green Version]
- Hazell, L.; Cornelius, V.; Hannaford, P.; Shakir, S.; Avery, A.J. How do patients contribute to signal detection? A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK’s Yellow Card Scheme. Drug Saf. 2013, 36, 199–206. [Google Scholar] [CrossRef]
- Shamseer, L.; Moher, D.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.A.; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 2015, 4, 1. [Google Scholar]
- Härmark, L.; van Hunsel, F.; Grundmark, B. ADR Reporting by the general public: Lessons learnt from the Dutch and Swedish systems. Drug Saf. 2015, 38, 337–347. [Google Scholar] [CrossRef] [PubMed]
- 2013 Annual Report. The Drug Control Department under the Government of the Republic of Lithuania. 2013. Available online: https://www.vvkt.lt/index.php?2417723960 (accessed on 15 June 2020).
- The State Medicines Control Agency under the Ministry of Health of the Republic of Lithuania (SMCA). 2020. Available online: https://www.vvkt.lt/index.php?3341007673 (accessed on 15 June 2020).
- 2019 Annual Report. The Drug Control Department under the Government of the Republic of Lithuania. 2019. Available online: https://www.vvkt.lt/index.php?2417723960 (accessed on 15 June 2020).
- Al Dweik, R.; Stacey, D.; Kohen, D.; Yaya, S. Factors affecting patient reporting of adverse drug reactions: A systematic review. Br. J. Clin. Pharmacol. 2017, 83, 875–883. [Google Scholar] [CrossRef] [Green Version]
- Wong, L.P. Focus group discussion: A tool for health and medical research. Singapore Med. J. 2008, 49, 256–260. [Google Scholar] [PubMed]
- Cameron, J. Focusing on the focus group. In Qualitative Research Methods in Human Geography, 2nd ed.; Hay, I., Ed.; Oxford University Press: Melbourne, Australia, 2005; pp. 156–182. [Google Scholar]
- Dawood, O.T.; Hassali, M.A.; Saleem, F. A qualitative study exploring medicines use pattern and practice among general public in Malaysia. Pharm. Pract. 2016, 14, 740. [Google Scholar] [CrossRef]
- Krska, J.; Jones, L.; McKinney, J.; Wilson, C. Medicine safety: Experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol. Drug Saf. 2011, 20, 1098–1103. [Google Scholar] [CrossRef] [PubMed]
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef] [Green Version]
- Elkalmi, R.; Hassali, M.A.; Al-Lela, O.Q.; Jawad Awadh, A.I.; Al-Shami, A.K.; Jamshed, S.Q. Adverse drug reactions reporting: Knowledge and opinion of general public in Penang, Malaysia. J. Pharm. Bioallied Sci. 2013, 5, 224–228. [Google Scholar] [PubMed]
- Jarernsiripornkul, N.; Patsuree, A.; Krska, J. Public confidence in ADR identification and their views on ADRreporting: Mixed methods study. Eur. J. Clin. Pharmacol. 2017, 73, 223–231. [Google Scholar] [CrossRef] [PubMed]
- Hughes, L.; Whittlesea, C.; Luscombe, D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J. Clin. Pharm. Ther. 2002, 27, 243–248. [Google Scholar] [CrossRef]
- Raynor, D.K.; Knapp, P. Do Patients See, Read and Retain the New Mandatory Medicines Information Leaflets? Pharmaceutical Journal. February 2000, Online|URI: 20000495. Available online: https://www.pharmaceutical-journal.com/do-patients-see-read-and-retain-the-new-mandatory-medicines-information-leaflets/20000495.article?firstPass=false (accessed on 15 June 2020).
- Sales, I.; Aljadhey, H.; Albogami, Y.; Mahmoud, M.A. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia. Saudi Pharm. J. 2017, 25, 868–872. [Google Scholar] [CrossRef]
- Avery, A.J.; Anderson, C.; Bond, C.M.; Fortnum, H.; Gifford, A.; Hannaford, P.C.; Hazell, L.; Krska, J.; Lee, A.J.; Mclernon, D.J.; et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: Literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol. Assess. 2011, 15. [Google Scholar] [CrossRef]
- Matos, C.; van Hunsel, F.; Joaquim, J. Are consumers ready to take part in the Pharmacovigilance System?—A Portuguese preliminary study concerning ADR reporting. Eur. J. Clin. Pharmacol. 2015, 71, 883–890. [Google Scholar] [CrossRef]
- Lebanova, H.; Getov, I. Study of Patients’ Potential as a Source for Spontaneous Reporting Systems in Bulgaria. Pharmacoepidemiol. Drug Saf. 2014, 23, 19–497. [Google Scholar]
- Walji, R.; Boon, H.; Barnes, J.; Austin, Z.; Welsh, S.; Baker, G.R. Consumers of natural health products: Natural-born pharmacovigilantes? BMC Complementary Altern. Med. 2010, 10, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Hunsel, F.P.; ten Berge, E.A.; Borgsteede, S.D.; van Grootheest, K. What motivates patients to report an adverse drug reaction? Ann. Pharmacother. 2010, 44, 936–937. [Google Scholar] [CrossRef]
- Iannone, L.F.; Bennardo, L.; Palleria, C.; Roberti, R.; De Sarro, C.; Naturale, M.D.; Dastoli, S.; Donato, L.; Manti, A.; Valenti, G.; et al. Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study. PLoS ONE 2020, 15, e0241575. [Google Scholar] [CrossRef] [PubMed]
- Haas, J.S.; Klinger, E.; Marinacci, L.X.; Brawarsky, P.; Orav, E.J.; Schiff, G.D.; Bates, D.W. Active pharmacovigilance and healthcare utilization. Am. J. Manag. Care 2012, 18, e423–e428. [Google Scholar] [PubMed]
- Huang, H.L.; Li, Y.C.; Chou, Y.C.; Hsieh, Y.W.; Kuo, F.; Tsai, W.C.; Chai, S.D.; Lin, B.Y.; Kung, P.T.; Chuang, C.J. Effects of and satisfaction with short message service reminders for patient medication adherence: A randomized controlled study. BMC Med. Inform. Decis. Mak. 2013, 13, 127. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liseckiene, I.; Liubarskiene, Z.; Jacobsen, R.; Valius, L.; Norup, M. Do family practitioners in Lithuania inform their patients about adverse effects of common medications? J. Med. Ethics 2008, 34, 137–140. [Google Scholar] [CrossRef]
FG | Age in Years (Min–Max) | Characteristic | Frequency | Total |
---|---|---|---|---|
FG 1 | 32–82 | Male | 3 | 8 |
Female | 5 | |||
FG 2 | 70–90 | Male | 4 | 14 |
Female | 10 | |||
FG 3 | 58–88 | Male | 2 | 12 |
Female | 10 | |||
FG 4 | 29–64 | Male | 4 | 8 |
Female | 4 | |||
Total | 42 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Valinciute-Jankauskiene, A.; Kubiliene, L. Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania. Healthcare 2021, 9, 303. https://doi.org/10.3390/healthcare9030303
Valinciute-Jankauskiene A, Kubiliene L. Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania. Healthcare. 2021; 9(3):303. https://doi.org/10.3390/healthcare9030303
Chicago/Turabian StyleValinciute-Jankauskiene, Agne, and Loreta Kubiliene. 2021. "Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania" Healthcare 9, no. 3: 303. https://doi.org/10.3390/healthcare9030303